Globus Medical (GMED) Cost of Revenue (2011 - 2026)

Globus Medical's Cost of Revenue history runs 16 years deep, the most recent figure standing at $234.1 million for Q1 2026.

• Quarterly Cost of Revenue rose 19.79% year-over-year to $234.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $996.5 million (up 0.72% YoY) and the FY2025 annual result came in at $957.8 million, down 7.5% from the prior year.
• Cost of Revenue was $234.1 million for Q1 2026 at Globus Medical, down from $261.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $270.5 million in Q3 2024 and bottomed at $59.2 million in Q1 2022.
• A 5-year average of $178.8 million and a median of $234.1 million in 2026 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue soared 276.09% — and 2025, when it decreased 19.09%.
• Globus Medical's Cost of Revenue stood at $70.6 million in 2022, then surged by 276.09% to $265.5 million in 2023, then dropped by 0.77% to $263.4 million in 2024, then retreated by 0.88% to $261.1 million in 2025, then decreased by 10.36% to $234.1 million in 2026.
• Business Quant data shows GMED's Cost of Revenue at $234.1 million in Q1 2026, $261.1 million in Q4 2025, and $252.5 million in Q3 2025.